Whitepaper
How trusted research data enables smarter decisions in life sciences
Discover ideal database features for life sciences R&D and Medical Affairs to unlock insights, ensure reliable data, and drive informed decisions.
Do you trust the outputs from your organization’s AI?
As more organizations input data into artificial intelligence (AI) models, it’s imperative that they know where the data comes from and what it means. When organizations don’t have data they can trust, decisions drift and costly gaps go unnoticed.
Organizations need the right type of data to truly drive informed decision-making, whether it’s details about a molecule in a clinical trial or the nuance of a patent’s claims.”
Get your free copy here
The full whitepaper on how trusted data drives better decision making, delivered straight to your inbox.
This whitepaper is for you if…
You work in R&D or Medical Affairs at a life sciences organization, and you’re being asked to move faster on evidence-based decisions while the data infrastructure behind those decisions hasn’t caught up — especially now that AI tools are entering the workflow.
- R&D teams: Evaluate targets beyond abstracts to justify resource allocation.
- Medical Affairs: Trace claims to original sources for regulatory and formulary compliance.
- Data leads: Define AI-ready, trustworthy infrastructure requirements before building or partnering.
What you’ll discover
This whitepaper gives R&D and Medical Affairs teams a framework to evaluate research data readiness and identify hidden gaps.
- Spot quality: Distinguish large databases from standardized, traceable sources.
- Leverage full-text: Use complete evidence, not just abstracts, for dossiers and submissions.
- Assess AI readiness: Determine if your infrastructure is truly prepared for AI tools.
More insights from our experts
AI with integrity: An interview for enterprise AI leaders
Why your AI agents are only as good as the knowledge behind them
